Skip to main navigation

Investors + Newsroom
Culture + Careers

Who We Are

Who We Are
Science & Innovation

Science & Innovation
Therapeutic Pipeline

Therapeutic Pipeline
Patients & Families

Patients & Families

Search
Investors + Newsroom
Culture + Careers

Event Details

Overview
News
Events + Presentations
Stock Information
Sec Filings
Corporate Governance
Shareholder Services

Morgan Stanley 22nd Annual Global Healthcare Conference

Sep 05, 2024 at 5:35 PM EDT

click here for webcast

Contact Us

Stay connected on REGENXBIO programs and our commitment to patients.

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy.

Contact Us

Terms and Conditions

Privacy Policy

© 2025 Regenxbio Inc. • "NAV®" is a registered trademark of REGENXBIO Inc. • All Rights Reserved